Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.
about
The molecular genetics and cellular mechanisms underlying pulmonary arterial hypertensionMicrovessel mechanobiology in pulmonary arterial hypertension: cause and effectA comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.Molecular and functional characterization of the BMPR2 gene in Pulmonary Arterial HypertensionInteraction between bone morphogenetic protein receptor type 2 and estrogenic compounds in pulmonary arterial hypertensionCytoskeletal defects in Bmpr2-associated pulmonary arterial hypertensionEstrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular MetabolismBone Marrow-derived Cells Contribute to the Pathogenesis of Pulmonary Arterial Hypertension.A potential role for insulin resistance in experimental pulmonary hypertensionRho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension.Targeting RhoA/ROCK pathway in pulmonary arterial hypertension.A process-based review of mouse models of pulmonary hypertension.Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations.Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension.The pathophysiological basis of chronic hypoxic pulmonary hypertension in the mouse: vasoconstrictor and structural mechanisms contribute equally.TGF-β and BMPR2 Signaling in PAH: Two Black Sheep in One Family
P2860
Q26992278-82651328-3B36-498F-A26A-CE9EED68E6B1Q27009717-BC52C8E2-3B1D-448E-B706-99F03DFC850BQ27026643-67E62777-70BA-4763-9A2B-16EC741F5B44Q30544892-0F318590-46AA-463D-97A7-0DB3862339B6Q33689573-B1B92960-1E41-418A-B810-1D8C0888B8EFQ33806083-0D9ABF31-9812-4929-810F-EE5E03FA3E24Q35850232-D1D9B8CB-C12A-4883-8DB7-55E89A1BCA76Q36421287-7EE52343-EA1E-4A7E-8F4D-0DDCCD51249FQ36847595-69F0A1BA-A176-4019-B17E-373E9C3571FDQ37104263-2E46D81D-931B-4F87-B1D1-1BEC9C7324ADQ37450106-57E8C7C9-ED5D-4CFF-992F-F711B605AD38Q37688533-013AD694-E539-419F-AC70-A64612CC4967Q37997101-1E9EC5BD-5281-4690-BA08-BBCA42A397ECQ38078369-0A1A800B-9A74-4D7F-95AF-0F2F75B722F7Q38642429-D1047879-77A5-47D4-BAE5-6A059BC663B3Q38779774-39F65C13-1866-4EEB-A091-136FC1BAE4EEQ46682354-1C1152EC-F6C9-4002-8072-82E0EF619861Q54527080-D2CD648D-2130-40CC-95BE-C493BC673538Q57166510-BA66BDE1-5005-4D43-9FBE-AD9F1CB8F3E5
P2860
Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rho-kinase inhibition alleviat ...... genetic protein receptor gene.
@en
Rho-kinase inhibition alleviat ...... genetic protein receptor gene.
@nl
type
label
Rho-kinase inhibition alleviat ...... genetic protein receptor gene.
@en
Rho-kinase inhibition alleviat ...... genetic protein receptor gene.
@nl
prefLabel
Rho-kinase inhibition alleviat ...... genetic protein receptor gene.
@en
Rho-kinase inhibition alleviat ...... genetic protein receptor gene.
@nl
P2093
P2860
P1476
Rho-kinase inhibition alleviat ...... ogenetic protein receptor gene
@en
P2093
Koichiro Tatsumi
Nobuhiro Tanabe
Tadashi Yasuda
P2860
P304
P356
10.1152/AJPLUNG.00423.2010
P577
2011-08-19T00:00:00Z